National Health Investors (NHI) Expected to Announce Quarterly Earnings on Monday
by Amy Steele · The Cerbat GemNational Health Investors (NYSE:NHI – Get Free Report) is expected to post its Q1 2026 results after the market closes on Monday, May 4th. Analysts expect National Health Investors to post earnings of $0.8550 per share and revenue of $70.2160 million for the quarter. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. Individuals can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Tuesday, May 5, 2026 at 10:00 AM ET.
National Health Investors (NYSE:NHI – Get Free Report) last issued its quarterly earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.01). National Health Investors had a net margin of 37.81% and a return on equity of 9.56%. The business had revenue of $105.82 million for the quarter, compared to the consensus estimate of $95.12 million. During the same quarter last year, the business posted $1.24 EPS. The business’s revenue was up 6.8% compared to the same quarter last year. On average, analysts expect National Health Investors to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.
National Health Investors Stock Performance
NYSE NHI opened at $76.97 on Monday. National Health Investors has a 52-week low of $68.80 and a 52-week high of $91.38. The company has a debt-to-equity ratio of 0.76, a quick ratio of 6.90 and a current ratio of 6.90. The company has a market capitalization of $3.73 billion, a P/E ratio of 25.49, a P/E/G ratio of 4.20 and a beta of 0.63. The company has a fifty day moving average of $84.81 and a 200-day moving average of $80.46.
National Health Investors Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Tuesday, March 31st will be issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date of this dividend is Tuesday, March 31st. National Health Investors’s payout ratio is currently 121.85%.
Institutional Trading of National Health Investors
Several hedge funds have recently added to or reduced their stakes in the business. Mercer Global Advisors Inc. ADV bought a new stake in National Health Investors in the fourth quarter worth $352,000. EP Wealth Advisors LLC bought a new stake in National Health Investors in the fourth quarter worth $351,000. NewEdge Advisors LLC lifted its stake in National Health Investors by 111.6% in the fourth quarter. NewEdge Advisors LLC now owns 10,202 shares of the real estate investment trust’s stock worth $779,000 after purchasing an additional 5,380 shares during the last quarter. Garton & Associates Financial Advisors LLC bought a new stake in National Health Investors in the fourth quarter worth $33,000. Finally, Voloridge Investment Management LLC lifted its stake in National Health Investors by 1.6% in the fourth quarter. Voloridge Investment Management LLC now owns 76,629 shares of the real estate investment trust’s stock worth $5,852,000 after purchasing an additional 1,238 shares during the last quarter. 62.51% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on NHI shares. National Bank Financial set a $85.00 price objective on shares of National Health Investors in a report on Tuesday, January 20th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of National Health Investors in a report on Friday, March 27th. Truist Financial dropped their price objective on shares of National Health Investors from $92.00 to $89.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft downgraded National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 target price for the company. in a research report on Tuesday, January 20th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $94.00 target price on shares of National Health Investors in a research report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $87.50.
Read Our Latest Stock Analysis on National Health Investors
National Health Investors Company Profile
National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.
Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.